NCT/Study#
NCT02956382 /
PRO2016-0014-C103287
Ibrutinib And Venetoclax In Relapsed And Refractory Follicular Lymphoma
DISEASE GROUP:
Lymphoma
current phase:
Phase I/II
STUDY STATUS:
Accepting Patients
Location:
Hackensack, NJ
For More information:
Call 201-518-3587
